EVALUATION OF THE EFFECTIVENESS OF VACCINATION AGAINST COVID-19(U07.1) OF THE POPULATION OF THE CITY OF JALAL-ABAD, JALAL-ABAD REGION OF THE KYRGYZ REPUBLIC IN THE PERIOD 2021
The article reflects the analysis of vaccination against COVID-19 of the population of the city of Jalal-Abad in the period from April 2021 to February 2022. Moderna mRNA-1273, the vaccination was started with the Vero-Cell vaccine, and subsequently carried out with different types of vaccines: - Sputnik V, Astra Zeneca, Qaz Vac, Pfizer - BioNTech, Sputnik- Light, Moderna mRNA-1273. Vaccination in the city was subject to - 44687 people older than 18 years. Vaccinated with 1 dose - 30853 (69%) people, 2 dose - 23906 (53%) people and 3 dose (booster dose) - 3361 (14%). The organization of vaccination among the population against coronavirus infection since April 2021, led to a decrease in the incidence of COVID-19 and created conditions for the formation of collective immunity, which prevented the occurrence of repeated outbreaks of the disease. In the city of Jalal-Abad with COVID-19, 683.2 per 100 thousand of the population fell ill, of which 27.5 per 100 thousand of the population were patients who received preventive vaccinations against corona virus infection. A large proportion of vaccinated cases was noted at the age of 30 to 64 years - 26 (5.2%), then 18 - 29 years - 5 (3.1%) and 65 years and older -3 (2.3%) patients.